fingolimod hydrochloride has been researched along with Amnionitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asci, H; Eris Yalcin, S; Ozmen, O; Sezik, M; Yavuz, A | 1 |
| Baumann, JM; Bhaumik, SK; Chougnet, CA; Dunn, RS; Kallapur, SG; Kuan, CY; Lee, YH; Lewkowich, IP; Li, Y; Lin, SH; Lin, X; Lindquist, DM; Liu, CY; Murali-Krishna, K; Shie, FS; Sun, YY; Wills-Karp, M; Yang, D; Zhang, Y | 1 |
2 other study(ies) available for fingolimod hydrochloride and Amnionitis
| Article | Year |
|---|---|
Immunohistochemical analysis of protective effects of maternal fingolimod on the placenta and fetal lung and brain in chorioamnionitis-induced preterm birth rat model.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Apoptosis Regulatory Proteins; Brain; Chorioamnionitis; Disease Models, Animal; Female; Fingolimod Hydrochloride; Immunohistochemistry; Inflammation Mediators; Lipopolysaccharides; Lung; Placenta; Pregnancy; Premature Birth; Rats, Wistar | 2020 |
Blocking lymphocyte trafficking with FTY720 prevents inflammation-sensitized hypoxic-ischemic brain injury in newborns.
Topics: Animals; Animals, Newborn; Atrophy; Blood-Brain Barrier; Brain; Cell Movement; Chorioamnionitis; Cytokines; Dose-Response Relationship, Drug; Female; Fingolimod Hydrochloride; Humans; Hypoxia-Ischemia, Brain; Immunosuppressive Agents; Infant, Newborn; Inflammation; Lipopolysaccharides; Lymphocyte Activation; Lymphocytes; NF-kappa B; Pregnancy; Propylene Glycols; Rats; Receptors, Interleukin; Sphingosine; T-Lymphocytes; White Matter | 2014 |